TrialWire, a leader in clinical trial recruitment innovation, launched its groundbreaking AI Voice Screen service as part of ...

The genomics industry is set for growth due to advancements in personalized medicine, diagnostics, and biotech innovations.

Cathie Wood and Ark Invest sold roughly $7,379,804 worth of Palantir stock — and spent $9,145,824 on three biotech stocks.

SAN FRANCISCO, Feb. 06, 2025 (GLOBE NEWSWIRE) -- TrialWire, a leader in clinical trial recruitment innovation, launched its groundbreaking AI Voice Screen service as part of the TrialWire Recruitment ...

AI-powered simulation software could help biomanufacturers understand the economics and sustainability of protein production at large scale.

A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...

Avid Bioservices poised for significant growth with new partners GHO Capital and Ampersand Capital Partners Acquisition of biologics Contract ...

The new sorghum varieties provide a climate-smart alternative grain for food science, breweries and dairy farmers ...

Living intelligence systems can sense, learn, adapt and evolve through the use of AI, advanced sensors and biotechnology, and ...

The first clinical trials using organs from genetically modified pigs offer hope to patients with kidney failure, who face a ...

The outcome of the 2024 U.S. election had far-reaching implications for the global investment landscape, especially in the dynamic field of ...